Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Clinical Pharmacokinetics|February 1, 1996
The use of therapeutic drug monitoring to optimise immunosuppressive therapyS M Tsunoda, F T AweekaBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Drug concentration monitoring of immunosuppressive agents: focus on tacrolimus, mycophenolate mofetil and sirolimusS M Tsunoda, F T AweekaThe Annals of Pharmacotherapy|November 24, 1998
Opioid antagonists in the treatment of pruritus from cholestatic liver diseaseS G Terra, S M TsunodaPharmacotherapy|November 5, 1997
A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantationS G Terra, T R Spitzer, S M TsunodaThe Annals of Pharmacotherapy|October 24, 1997
Ursodiol to prevent hepatic venoocclusive diseaseS A Comcowich, T R Spitzer, S M TsunodaJournal of Clinical Pharmacology|April 17, 2001
Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal womenS M Tsunoda, R Z Harris, P J Mroczkowski, et al.Pharmacotherapy|October 8, 1999
A review of interleukin-2 receptor antagonists in solid organ transplantationJ L Berard, R L Velez, R B Freeman, et al.Clinical Pharmacology and Therapeutics|April 1, 1996
The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokineticsR Z Harris, S M Tsunoda, P Mroczkowski, et al.Clinical Pharmacology and Therapeutics|December 1, 1999
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazoleS M Tsunoda, R L Velez, L L von Moltke, et al.Clinical Pharmacology and Therapeutics|November 24, 2001
Red wine decreases cyclosporine bioavailabilityS M Tsunoda, R Z Harris, U Christians, et al.Pageof 2